269 related articles for article (PubMed ID: 34051351)
21. The microbiota and microbiome in pancreatic cancer: more influential than expected.
Wei MY; Shi S; Liang C; Meng QC; Hua J; Zhang YY; Liu J; Zhang B; Xu J; Yu XJ
Mol Cancer; 2019 May; 18(1):97. PubMed ID: 31109338
[TBL] [Abstract][Full Text] [Related]
22. Regulation and modulation of antitumor immunity in pancreatic cancer.
Leinwand J; Miller G
Nat Immunol; 2020 Oct; 21(10):1152-1159. PubMed ID: 32807942
[TBL] [Abstract][Full Text] [Related]
23. The Microbiome and Liver Cancer.
Myojin Y; Greten TF
Cancer J; 2023 Mar-Apr 01; 29(2):57-60. PubMed ID: 36957974
[TBL] [Abstract][Full Text] [Related]
24. Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer.
Dong J; Gao HL; Wang WQ; Yu XJ; Liu L
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188484. PubMed ID: 33246025
[TBL] [Abstract][Full Text] [Related]
25. The Unique Microbiome and Immunity in Pancreatic Cancer.
Wei X; Mei C; Li X; Xie Y
Pancreas; 2021 Feb; 50(2):119-129. PubMed ID: 33565788
[TBL] [Abstract][Full Text] [Related]
26. Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review).
Huang X; Li M; Hou S; Tian B
Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34738624
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy in Pancreatic Adenocarcinoma: Beyond "Copy/Paste".
Hester R; Mazur PK; McAllister F
Clin Cancer Res; 2021 Dec; 27(23):6287-6297. PubMed ID: 34193514
[TBL] [Abstract][Full Text] [Related]
28. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
29. Intratumor Microbiome Analysis Identifies Positive Association Between
Huang Y; Zhu N; Zheng X; Liu Y; Lu H; Yin X; Hao H; Tan Y; Wang D; Hu H; Liang Y; Li X; Hu Z; Yin Y
Front Immunol; 2022; 13():785422. PubMed ID: 35145519
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
[TBL] [Abstract][Full Text] [Related]
31. Targeting microbiome, drug metabolism, and drug delivery in oncology.
Sumiyoshi A; Fujii H; Okuma Y
Adv Drug Deliv Rev; 2023 Aug; 199():114902. PubMed ID: 37263544
[TBL] [Abstract][Full Text] [Related]
32. The role of the microbiome in drug resistance in gastrointestinal cancers.
Garajová I; Balsano R; Wang H; Leonardi F; Giovannetti E; Deng D; Peters GJ
Expert Rev Anticancer Ther; 2021 Feb; 21(2):165-176. PubMed ID: 33115280
[No Abstract] [Full Text] [Related]
33. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.
Ciernikova S; Novisedlakova M; Cholujova D; Stevurkova V; Mego M
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33287196
[TBL] [Abstract][Full Text] [Related]
34. Microbiota: A key factor affecting and regulating the efficacy of immunotherapy.
Jiang Y; Jia D; Sun Y; Ding N; Wang L
Clin Transl Med; 2023 Dec; 13(12):e1508. PubMed ID: 38082435
[TBL] [Abstract][Full Text] [Related]
35. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
[TBL] [Abstract][Full Text] [Related]
36. Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma.
Pandey V; Storz P
Expert Rev Anticancer Ther; 2019 Jun; 19(6):473-482. PubMed ID: 31148495
[No Abstract] [Full Text] [Related]
37. Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy.
Zhou P; Hu Y; Wang X; Shen L; Liao X; Zhu Y; Yu J; Zhao F; Zhou Y; Shen H; Li J
Front Immunol; 2022; 13():877939. PubMed ID: 36003378
[TBL] [Abstract][Full Text] [Related]
38. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
[TBL] [Abstract][Full Text] [Related]
39. Advances in immunotherapy for pancreatic ductal adenocarcinoma.
Miyazawa M; Katsuda M; Kawai M; Hirono S; Okada KI; Kitahata Y; Yamaue H
J Hepatobiliary Pancreat Sci; 2021 May; 28(5):419-430. PubMed ID: 33742512
[TBL] [Abstract][Full Text] [Related]
40. Clinical potential of microbiota in thyroid cancer therapy.
Xie Z; Zhou J; Zhang X; Li Z
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166971. PubMed ID: 38029942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
